Statistical and graphical approaches for disproportionality analysis of spontaneously-reported adverse events in pharmacovigilance

被引:22
|
作者
Zink, Richard C. [1 ]
Huang Qin [2 ]
Zhang Lu-Yong [3 ]
Bao Wen-Jun [1 ]
机构
[1] SAS Inst Inc, Cary, NC USA
[2] SFDA, Ctr Drug Evaluat, Beijing 100053, Peoples R China
[3] China Pharmaceut Univ, Jiangsu Ctr Drug Screening, Nanjing 210009, Peoples R China
关键词
Disproportionality; Statistics; Graphics; Pharmacovigilance; Spontaneously-reported adverse events; SIGNAL GENERATION;
D O I
10.1016/S1875-5364(13)60035-7
中图分类号
R [医药、卫生];
学科分类号
10 ;
摘要
AIM: Combine disproportionality analysis with dynamically interactive graphics to understand spontaneously-reported adverse events in pharmacovigilance. METHODS: Four statistical methods, including Reporting Odds Ratio, Proportional Reporting Ratio, Multi-Item Gamma Poisson Shrinker and Bayesian Confidence Propagation Neural Network that are used for computing disproportionality are described. Tree maps and other graphical techniques are used to display the disproportionality results. RESULTS: Spontaneously-reported adverse events in pharmacovigilance are collected from physicians, patients, or the medical literature by regulatory agencies, pharmaceutical companies and device manufacturers to monitor the safety of a product once it reaches the market. In order to identify potential safety-signals, disproportionality analysis methods compare the rate at which a particular event of interest co-occurs with a given drug with the rate this event occurs without the drug in the event database. Tree maps are employed to interactively display the adverse events for particular drugs and compare the adverse events among the drugs. CONCLUSIONS: Interactive graphical displays of disproportionality allow the analyst to quickly identify safety signals and perform additional follow-up analyses. Combining statistical methods with dynamically interactive graphics affords insights into the data inaccessible by traditional analysis methods.
引用
收藏
页码:314 / 320
页数:7
相关论文
共 50 条
  • [21] Assessment of signals generated from spontaneously reported adverse events
    Amery, WK
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 1999, 8 (04) : 301 - 304
  • [22] A real-world pharmacovigilance study of omalizumab using disproportionality analysis in the FDA adverse drug events reporting system database
    Song, Yongfu
    Wang, Zhuang
    Wang, Na
    Xie, Xiaofei
    Zhu, Tieshi
    Wang, Yongji
    SCIENTIFIC REPORTS, 2025, 15 (01):
  • [23] Disproportionality analysis of spontaneously reported hypoglycemia events due to insulin use: A comparison between insulin detemir and insulin degludec using the Korea Adverse Event Reporting System
    Jeong, DaWo
    Kim, Won
    Shin, Ju-Young
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 2021, 59 (03) : 224 - 230
  • [24] Disproportionality analysis of vibegron-associated adverse events using the FDA adverse event reporting system (FAERS): a real-world pharmacovigilance study
    Bangbei Wan
    Zhi Zhou
    Ning Ma
    Weiying Lu
    European Journal of Medical Research, 30 (1)
  • [25] Spontaneously reported haemorrhagic adverse events associated with rivaroxaban and dabigatran in Australia
    Chen, Esa Y. H.
    Diug, Basia
    Bell, J. Simon
    Mc Namara, Kevin P.
    Dooley, Michael J.
    Kirkpatrick, Carl M.
    McNeil, John J.
    Caughey, Gillian E.
    Ilomaki, Jenni
    THERAPEUTIC ADVANCES IN DRUG SAFETY, 2016, 7 (01) : 4 - 10
  • [26] Safety of human albumin based on spontaneously reported serious adverse events
    von Hoegen, I
    Waller, C
    CRITICAL CARE MEDICINE, 2001, 29 (05) : 994 - 996
  • [27] Spontaneously Reported Hepatic Adverse Drug Events in Korea: Multicenter Study
    Kwon, Hee
    Lee, Suk-Hyang
    Kim, Seong-Eun
    Lee, Jae-Hyun
    Jee, Yung-Koo
    Kang, Hye-Ryun
    Park, Byung-Joo
    Park, Jung-Won
    Hong, Chein-Soo
    JOURNAL OF KOREAN MEDICAL SCIENCE, 2012, 27 (03) : 268 - 273
  • [28] Association Between Major Cardiovascular Events and Esketamine: A Disproportionality Analysis in the WHO Pharmacovigilance Database
    De Laportaliere, Tanguy Taillefer
    Lepetit, Marianne
    Yrondi, Antoine
    Montastrue, Francois
    DRUG SAFETY, 2024, 47 (12) : 1314 - 1314
  • [29] Influence of rapidly increased numbers of reports on adverse events of the COVID-19 vaccine in the Japanese pharmacovigilance database on disproportionality analysis of antineoplastic drug-associated adverse cardiovascular events
    Matsuo, Hajime
    Tanaka, Hiroyuki
    Endo, Kiri
    Ishii, Toshihiro
    EXPERT OPINION ON DRUG SAFETY, 2025,
  • [30] Disproportionality analysis of reported drug adverse events to assess a potential safety signal for pentavalent vaccine in 2019 in El Salvador
    Elas, Miguel
    Villatoro, Nora
    Pezzoli, Lorenzo
    VACCINE, 2021, 39 (34) : 4849 - 4855